Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -10.0912.99274.74-63.19-1.98

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is -10.09 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-10.09
Mar202212.99
Mar2021274.74
Mar2020-63.19
Mar2019-1.98

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74
Positive
Mar2020 -63.19
Negative
Mar2019 -1.98 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹160.5 Cr -1.7% -1.3% 16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,071.0 Cr 0.2% -6.1% 55.7% Stock Analytics
CIPLA ₹111,808.0 Cr -2.5% -5.1% 48.6% Stock Analytics
DIVIS LABORATORIES ₹104,300.0 Cr -0.9% 5% 19.2% Stock Analytics
ZYDUS LIFESCIENCES ₹101,202.0 Cr 1.8% 2.2% 88.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,035.0 Cr -3.7% -1.4% 26% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1.7%

-1.3%

16.9%

SENSEX

-1.4%

-0.6%

20.1%


You may also like the below Video Courses